Therapeutic options for the treatment of multiple sclerosis

• Autor(a) principal: Nery, Lara Gomes
• Data de Publicação: 2022
• Outros Autores: Costa, Ana Cláudia Maia Mendonça da, Ribeiro, Gabriela Ramos, Oliveira, Gustavo Silva, Vaz, Rodolfo Lopes, Arruda, Jalsi Tacon
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Research, Society and Development
• Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/26331
• topic: Esclerose Disseminada; Terapêutica; Terapias complementares.; Esclerosis diseminada; Terapia; Terapias complementarias.; Disseminated sclerosis; Therapy; Complementary therapies.

Multiple Sclerosis (MS) is a chronic degenerative disease that affects the central nervous system. Treatment is aimed at reducing the inflammatory process and delaying the progression of the disease. This work analyzes the existing and currently available therapeutic options for the treatment of patients with multiple sclerosis. An epidemiological study was carried out, based on an integrative review of data available in PubMed, SciELO and Google Scholar, using the descriptors “multiple sclerosis” and “treatment”. Pharmacological therapy for MS can be used for symptomatic treatment, for acute episodes/outbreaks, or for the use of disease-modifying drugs. The existing variety of disease-modifying drugs allows flexibility in choosing the best option according to each patient's profile. In addition to drug treatments, complementary therapies are important for neurorehabilitation and symptom control, such as psychology, speech therapy, neuropsychology, physical therapy and occupational therapy. Other points recently discussed in the treatment of MS are the supplementary use of vitamin D, the use of cannabinoid compounds, and a future perspective of autologous stem cell transplantation. Considering the prevalence and impact of MS on the long-term quality of life of patients, the importance of early diagnosis and initiation of treatment, as well as the search for new evidence for the best possible therapeutic management of MS are fundamental for quality of life. of the patient.